Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19. by Marissa J M Traets, Roel H T Nijhuis, Servaas A Morré, Sander Ouburg, Jasper A Remijn, Bastiaan A Blok, Bas de Laat, Eefje Jong, Gerarda J M Herder, Aernoud T L Fiolet, Stephan P Verweij

Get full text

Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial by Niekbachsh Mohammadnia, Britta E. Wesselink, Willem A. Bax, Stefan M. Nidorf, Arend Mosterd, Aernoud T.L. Fiolet, Aysun Cetinyurek‐Yavuz, Peter L. Thompson, Shrikant I. Bangdiwala, John W. Eikelboom, Jan H. Cornel, Saloua El Messaoudi

Get full text

Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial by Marte F. van der Bijl, Jenny van der Veen, Aernoud T.L. Fiolet, Eric Boersma, Jan H. Cornel, John W. Eikelboom, Stefan M. Nidorf, Peter L. Thompson, Jalina Jannink, Iris C.D. Westendorp, Arend Mosterd, Hester M. den den Ruijter, Jeanine E. Roeters van Lennep

Get full text